Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions

Title
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions
Authors
Keywords
Renal cell carcinoma, Tyrosine kinase inhibitor, PD-1/PD-L1, Immunotherapy, Combination therapy
Journal
EUROPEAN UROLOGY
Volume 75, Issue 1, Pages 100-110
Publisher
Elsevier BV
Online
2018-10-13
DOI
10.1016/j.eururo.2018.10.010

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now